AR117730A1 - Composición para relajación muscular - Google Patents
Composición para relajación muscularInfo
- Publication number
- AR117730A1 AR117730A1 ARP190103794A ARP190103794A AR117730A1 AR 117730 A1 AR117730 A1 AR 117730A1 AR P190103794 A ARP190103794 A AR P190103794A AR P190103794 A ARP190103794 A AR P190103794A AR 117730 A1 AR117730 A1 AR 117730A1
- Authority
- AR
- Argentina
- Prior art keywords
- peptide
- composition
- relaxation
- muscle
- physiological activities
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000003387 muscular Effects 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 230000001766 physiological effect Effects 0.000 abstract 2
- 210000002374 sebum Anatomy 0.000 abstract 2
- 230000037303 wrinkles Effects 0.000 abstract 2
- 208000002874 Acne Vulgaris Diseases 0.000 abstract 1
- 206010021118 Hypotonia Diseases 0.000 abstract 1
- 206010000496 acne Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 210000003205 muscle Anatomy 0.000 abstract 1
- 230000036640 muscle relaxation Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001629 suppression Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Birds (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Peptides Or Proteins (AREA)
- Rigid Containers With Two Or More Constituent Elements (AREA)
- Laminated Bodies (AREA)
Abstract
La presente se refiere a un péptido que exhibe actividades fisiológicas y a una composición que incluye el péptido. Debido a que el péptido de la presente exhibe diversas actividades fisiológicas tales como relajación muscular, mejora de las arrugas de la piel, supresión de la producción de sebo, y lo similar, el péptido puede ser utilizado como ingrediente activo en una composición farmacéutica para relajación muscular, o como cosmético para mejorar las arrugas de la piel, suprimir la producción de sebo o mejorar el acné.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20180169495 | 2018-12-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR117730A1 true AR117730A1 (es) | 2021-08-25 |
Family
ID=71571557
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP190103794A AR117730A1 (es) | 2018-12-26 | 2019-12-20 | Composición para relajación muscular |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US11306121B2 (es) |
| EP (1) | EP3815674B1 (es) |
| JP (1) | JP7110405B2 (es) |
| KR (1) | KR102132274B1 (es) |
| CN (1) | CN112367967B (es) |
| AR (1) | AR117730A1 (es) |
| CA (1) | CA3103204C (es) |
| EA (1) | EA202092820A1 (es) |
| ES (1) | ES3049603T3 (es) |
| IL (1) | IL279386B2 (es) |
| MX (1) | MX2020014330A (es) |
| MY (1) | MY198172A (es) |
| PH (1) | PH12020552142A1 (es) |
| SG (1) | SG11202100812UA (es) |
| TW (1) | TWI730562B (es) |
| UA (1) | UA125331C2 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102483938B1 (ko) * | 2020-06-12 | 2023-01-04 | (주)케어젠 | 펜타펩타이드를 유효성분으로 포함하는 항알러지 또는 아토피피부염 개선용 조성물 |
| KR102463320B1 (ko) * | 2020-06-12 | 2022-11-07 | (주)케어젠 | 펜타펩타이드를 유효성분으로 포함하는 통증의 완화, 예방 또는 치료용 조성물 |
| CN115916236B (zh) * | 2020-06-12 | 2025-08-15 | 凯尔格恩有限公司 | 包含五肽作为活性成分的组合物 |
| CN114560912B (zh) * | 2022-03-28 | 2023-10-20 | 碧悦星泽(北京)生物医药科技有限公司 | 一种具有抗皱功能的多肽及其复合物与应用 |
| KR102772405B1 (ko) * | 2022-06-10 | 2025-02-26 | (주)케어젠 | 근육 손실 저해 및 근육량 증진 활성을 갖는 펩타이드 및 이의 용도 |
| KR20240086947A (ko) * | 2022-12-09 | 2024-06-19 | (주)케어젠 | 연골 재생용 펩타이드 및 이의 용도 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2160485B1 (es) * | 1999-04-23 | 2002-05-16 | Lipotec Sa | Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen. |
| CN101720331A (zh) | 2007-06-01 | 2010-06-02 | 德国麦氏大药厂 | 基于肉毒毒素的神经毒成分供应温度-稳定性肌肉松弛剂的方法 |
| CN104083752B (zh) * | 2007-06-27 | 2018-04-10 | 里兰斯坦福初级大学理事会 | 寡肽酪氨酸酶抑制剂及其应用 |
| EP2224955A4 (en) * | 2007-11-27 | 2011-02-16 | Univ British Columbia | 14-3-3 ANTAGONISTS FOR THE PREVENTION AND TREATMENT OF ARTHRITIS |
| GB201319620D0 (en) * | 2013-11-06 | 2013-12-18 | Norwegian University Of Science And Technology | Immunosuppressive agents and their use in therapy |
| GB201319621D0 (en) * | 2013-11-06 | 2013-12-18 | Norwegian University Of Science And Technology | Antimicrobial agents and their use in therapy |
-
2019
- 2019-01-31 MX MX2020014330A patent/MX2020014330A/es unknown
- 2019-07-10 KR KR1020190083008A patent/KR102132274B1/ko active Active
- 2019-10-22 US US17/251,609 patent/US11306121B2/en active Active
- 2019-10-22 EA EA202092820A patent/EA202092820A1/ru unknown
- 2019-10-22 EP EP19904095.7A patent/EP3815674B1/en active Active
- 2019-10-22 UA UAA202100134A patent/UA125331C2/uk unknown
- 2019-10-22 MY MYPI2020006476A patent/MY198172A/en unknown
- 2019-10-22 CA CA3103204A patent/CA3103204C/en active Active
- 2019-10-22 IL IL279386A patent/IL279386B2/en unknown
- 2019-10-22 CN CN201980042074.2A patent/CN112367967B/zh active Active
- 2019-10-22 SG SG11202100812UA patent/SG11202100812UA/en unknown
- 2019-10-22 ES ES19904095T patent/ES3049603T3/es active Active
- 2019-10-22 JP JP2020568427A patent/JP7110405B2/ja active Active
- 2019-12-20 AR ARP190103794A patent/AR117730A1/es unknown
- 2019-12-25 TW TW108147702A patent/TWI730562B/zh active
-
2020
- 2020-12-11 PH PH12020552142A patent/PH12020552142A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR102132274B1 (ko) | 2020-07-09 |
| IL279386B1 (en) | 2025-05-01 |
| UA125331C2 (uk) | 2022-02-16 |
| TW202024116A (zh) | 2020-07-01 |
| US20210246165A1 (en) | 2021-08-12 |
| CN112367967B (zh) | 2023-04-04 |
| CN112367967A (zh) | 2021-02-12 |
| TWI730562B (zh) | 2021-06-11 |
| PH12020552142A1 (en) | 2021-06-28 |
| SG11202100812UA (en) | 2021-02-25 |
| EP3815674B1 (en) | 2025-08-13 |
| BR112020026825A2 (pt) | 2021-07-27 |
| CA3103204A1 (en) | 2020-07-02 |
| MX2020014330A (es) | 2021-03-09 |
| KR20200080108A (ko) | 2020-07-06 |
| US11306121B2 (en) | 2022-04-19 |
| IL279386A (en) | 2021-01-31 |
| IL279386B2 (en) | 2025-09-01 |
| ES3049603T3 (en) | 2025-12-17 |
| EA202092820A1 (ru) | 2021-02-09 |
| EP3815674A1 (en) | 2021-05-05 |
| MY198172A (en) | 2023-08-09 |
| JP2021526154A (ja) | 2021-09-30 |
| CA3103204C (en) | 2023-08-01 |
| JP7110405B2 (ja) | 2022-08-01 |
| EP3815674A4 (en) | 2021-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR117730A1 (es) | Composición para relajación muscular | |
| CL2017002939A1 (es) | Composiciones farmacéuticas tópicas | |
| PH12018550062A1 (en) | Topical film-forming spray | |
| MX2019010757A (es) | Métodos y composiciones relacionados con el tratamiento combinado con antiinflamatorios y nanoportadores sintéticos que comprenden un inmunosupresor. | |
| CO2018001375A2 (es) | Composiciones de retinoides tópicos | |
| MX349594B (es) | Composicion para uso cosmetico adecuada para producir un efecto de pigmentacion sobre el cabello. | |
| BR112015005339A8 (pt) | uso de óleo de semente de fruta milagrosa como um ingrediente ativo | |
| PH12019502874A1 (en) | Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments | |
| BR112015029815A2 (pt) | composição cosmética para clarear uma pele e/ou cabelo de um indivíduo, conjunto para clarear uma pele e/ou um cabelo de um individuo, método cosmético para clarear uma pele e/ou um cabelo de um individuo, composição cosmética ou farmacêutica para aplicação na pele, cabelo e/ou unha de um indivíduo, conjunto para aplicar uma composição cosmética ou farmacêutica na pele cabelo e/ou unha de um individuo e método de administração de peróxido de hidrogênio na pele, cabelo e/ou unha de indivíduo. | |
| MX379253B (es) | Formulaciones de oximetazolina estabilizadas y sus usos. | |
| MX2022014577A (es) | Gel intestinal de levodopa y carbidopa y metodos de uso. | |
| MX2019011951A (es) | Secretoma bacteriano para usarse en el tratamiento contra lesiones cutaneas. | |
| MX2020010747A (es) | Formulaciones topicas que comprenden estroncio y metilsulfonilmetano (msm) y metodos de tratamiento. | |
| SG11201900925YA (en) | Non-invasive transportation method | |
| BR112015020182A2 (pt) | uso cosmético de queuina ou de um precursor ou um derivado dessa como ingrediente ativo, uso de queuina ou um precursor ou um derivado dessa como ingrediente ativo, composição cosmética e processo de tratamento cosmético para prevenir e/ou tratar sinais de envelhecimento da pele e/ou anexos cutâneos | |
| MX2022013816A (es) | Composicion farmaceutica para usarse en el aumento del cabello, la modificacion del cuero cabelludo o la piel, la cicatrizacion de una herida, la estimulacion de osteogenesis o la modificacion del cabello. | |
| AR103903A1 (es) | Composición cosmética reductiva de aplicación tópica | |
| BR112014032850A2 (pt) | combinações de princípios ativos, preparações cosméticas ou dermatológicas, e, uso de combinações de princípios ativos | |
| MX2017013265A (es) | Composicion para formulacion cosmetica humectante de larga duracion que comprende manteca de ucuuba con altas concentraciones de acido miristico asi como el uso de la formulacion para la preparacion de un producto cosmetico altamente humectante y kit. | |
| CL2024002320A1 (es) | Composición tópica que comprende un extracto de ophiopogon para uso en el tratamiento de los párpados o el contorno del ojo | |
| WO2015017775A3 (en) | Compositions having early lineage adult stem cells and extracts thereof | |
| MX356128B (es) | Uso del mucílago de nopal opuntia ficus-indica en combinación con agentes humectantes convencionales como ingredientes activos en composiciones cosméticas y/o demartológicas. | |
| AR104699A1 (es) | Composición farmacéutica tópica en emulsión y su uso para fabricar un medicamento | |
| MX395001B (es) | Composición y método para el tratamiento tópico del acné severo. | |
| BR112017001434A2 (pt) | composição farmacêutica, regimes para tratamentos terapêuticos das lesões acneicas e uso de 0,3% em peso de adapaleno |